Characterization of Pasteurella multocida strains isolated from human infections

Comp Immunol Microbiol Infect Dis. 2019 Apr:63:37-43. doi: 10.1016/j.cimid.2018.12.008. Epub 2019 Jan 4.

Abstract

Isolates of Pasteurella multocida recovered from infected humans (n = 15) were characterized by traditional and molecular microbiological methods and were compared with cat-derived strains (n = 5). The most prevalent subspecies among strains from human infections was P. multocida subsp. septica (80%), and nearly all isolates showed a similar combination of virulence-associated genes. MLST analysis classified the 20 P. multocida strains into 16 different sequence types, and we assigned 11 new sequence types (ST), however, only one of those (ST 334) was shared by two human and one cat isolates. P. multocida subsp. septica strains formed a distinct phylogenetic group within the species. The strains showed resistance to erythromycin, clindamycin and sulfamethoxazole, and with two exceptions, resistance to tilmicosin was also detected. Each strain was susceptible to ampicillin, streptomycin, gentamycin, tetracycline, doxycycline, cefazolin, cefpodoxime, chloramphenicol, florfenicol and enrofloxacin. Common characteristics (virulence profile and antibiotic sensitivity pattern) shared by strains isolated from humans and cats support the view that domestic cats may serve as a potential reservoir for P. multocida.

Keywords: Antimicrobial resistance; Human infections; Multilocus sequence typing; Pasteurella multocida.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Cats
  • Clindamycin / pharmacology
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Erythromycin / pharmacology
  • Humans
  • Microbial Sensitivity Tests
  • Multilocus Sequence Typing
  • Pasteurella Infections / microbiology*
  • Pasteurella Infections / veterinary*
  • Pasteurella multocida / classification
  • Pasteurella multocida / genetics*
  • Pasteurella multocida / isolation & purification
  • Pasteurella multocida / pathogenicity*
  • Sulfamethoxazole / pharmacology
  • Tylosin / analogs & derivatives
  • Tylosin / pharmacology
  • Virulence / genetics

Substances

  • Anti-Bacterial Agents
  • Clindamycin
  • Erythromycin
  • Sulfamethoxazole
  • tilmicosin
  • Tylosin